Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-716-3 | CAS number: 109-89-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: other routes
Administrative data
- Endpoint:
- acute toxicity: other routes
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Remarks:
- exposure route (i.p.) not relevant for human exposure
Data source
Reference
- Reference Type:
- secondary source
- Title:
- Serum enzymes as indicators of chemically induced liver damage
- Author:
- Drotman, R. and Lawhorn, G.
- Year:
- 1 978
- Bibliographic source:
- Drug and Chemical Toxicology, 1(2) : 163-171 (166)
Materials and methods
- Principles of method if other than guideline:
- Study was preformed to investigate liver enzymes as biomarkers for liver damage.
Test material
- Reference substance name:
- Diethylamine
- EC Number:
- 203-716-3
- EC Name:
- Diethylamine
- Cas Number:
- 109-89-7
- Molecular formula:
- C4H11N
- IUPAC Name:
- diethylamine
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Cox
- Sex:
- male
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- physiological saline
- Doses:
- 0, 250, 500 and 1000 mg/kg bw
- No. of animals per sex per dose:
- 20 (males only)
- Control animals:
- not specified
Results and discussion
- Mortality:
- no data
- Clinical signs:
- no data
- Body weight:
- no data
- Gross pathology:
- no data
Any other information on results incl. tables
Liver histopathology:
At 250 mg/kg bw dilated sinusoids after 2 h and mild degeneration/disruption of lobular pattern after 6 h. From 12 hours post-dosing no abnormalities were noted.
At 500 mg/kg bw mild degeneration/disruption of lobular pattern after 2 h, periportal necrosis and hydropic degeneration at 6 h and dilated sinusoids at 12 h. At 24 and 48 h post-dosing no abnormalities were noted.
At 1000 mg/kg bw periportal necrosis and hydropic degeneration at 2 h, disruption of lobular pattern at 6 h and dilated sinusoids at 12 and 24 h. At 48 h no abnormalities were detected.
Haematology: significantly increased ornithine carbamyl transferase at 2, 6 and 12 h (500 and 1000 mg/kg); significantly increased aspartate aminotransferase at 2, 6 and 12 h (500 and 1000 mg/kg); significantly increased alanina aminotransferase at 1000 mg/kg at 2, 6 and 12 hours; significanlty increased sorbitol dehydrogenase at 500 mg/kg at 6 h; effects decreased with increased sampling time.
Applicant's summary and conclusion
- Conclusions:
- Intraperitoneal administration of the test substance induced histopathological liver abnormalities and liver enzyme changes.
- Executive summary:
The study was performed to investigate liver enzymes as biomarkers for liver damage. Male rats were exposed to different doses of the test substance (250, 500 and 1000 mg/kg bw) intraperitoneal and sacrificed after 2, 6, 12, 24 and 48 hours of dosing.
The time and magnitude of peak liver injury were assessed by histopathological examination of the liver. Moreover, serum enzyme measurements were performed. Histopathological abnormalities were detected for all dosages. The highest dose tested caused periportal necrosis and hydropic degeneration in animals sacrificed 2 h after substance application. Liver enzymes were induced. With increasing sampling time the effects on the liver and liver enzymes decreased. No mortality data are recorded, thus no LD50 after intraperitoneal administration was derived.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.